DIAGNOSTEAR TECHNOLOGIES INC.DIAGNOSTEAR TECHNOLOGIES INC.DIAGNOSTEAR TECHNOLOGIES INC.

DIAGNOSTEAR TECHNOLOGIES INC.

No trades
See on Supercharts

DTR fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

DiagnosTear Technologies, Inc. is an ophthalmic company, which engages in the developing and commercializing disruptive diagnostic solutions for better management of eye diseases. Its products include TeaRx Dry Eye, TeaRx Red Eye, and TeaRx Tear Collector. The company was founded on May 10, 2023 and is headquartered in Vancouver, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
DTR has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company